1
|
McMillen IC and Robinson JS: Developmental
origins of the metabolic syndrome: prediction, plasticity, and
programming. Physiol Rev. 85:571–633. 2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Barker DJ: The developmental origins of
chronic adult disease. Acta Paediatr Suppl. 93:26–33. 2004.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Gluckman PD, Lillycrop KA, Vickers MH,
Pleasants AB, Phillips ES, et al: Metabolic plasticity during
mammalian development is directionally dependent on early
nutritional status. Proc Natl Acad Sci USA. 104:12796–12800. 2007.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Johnson AD, Newton CC, Chasman DI, Ehret
GB, Johnson T, et al; Cohorts for Heart and Aging Research in
Genomic Epidemiology Consortium; Global BPgen Consortium; Women’s
Genome Health Study. Association of hypertension drug target genes
with blood pressure and hypertension in 86,588 individuals.
Hypertension. 57:903–910. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Lima SG, Hatagima A and Silva NL:
Renin-angiotensin system: is it possible to identify hypertension
susceptibility genes? Arq Bras Cardiol. 89:427–433. 2007.PubMed/NCBI
|
6
|
Marcano AC, Onipinla AK, Caulfield MJ and
Munroe PB: Recent advances in the identification of genes for human
hypertension. Expert Rev Cardiovasc Ther. 3:733–741. 2005.
View Article : Google Scholar : PubMed/NCBI
|
7
|
McBride MW, Graham D, Delles C and
Dominiczak AF: Functional genomics in hypertension. Curr Opin
Nephrol Hypertens. 15:145–151. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Bautista LE, Vera LM, Arenas IA and
Gamarra G: Independent association between inflammatory markers
(C-reactive protein, interleukin-6, and TNF-α) and essential
hypertension. J Hum Hypertens. 19:149–154. 2005.
|
9
|
Sesso HD, Buring JE, Rifai N, Blake GJ,
Gaziano JM and Ridker PM: C-reactive protein and the risk of
developing hypertension. JAMA. 290:2945–2951. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Parissis JT, Korovesis S, Giazitzoglou E,
Kalivas P and Katritsis D: Plasma profiles of peripheral
monocyte-related inflammatory markers in patients with arterial
hypertension. Correlations with plasma endothelin-1. Int J Cardiol.
83:13–21. 2002. View Article : Google Scholar
|
11
|
Samuelsson AM, Ohrn I, Dahlgren J,
Eriksson E, Angelin B, et al: Prenatal exposure to interleukin-6
results in hypertension and increased
hypothalamic-pituitary-adrenal axis activity in adult rats.
Endocrinology. 145:4897–4911. 2004. View Article : Google Scholar : PubMed/NCBI
|
12
|
Samuelsson AM, Jennische E, Hansson HA and
Holmäng A: Prenatal exposure to interleukin-6 results in
inflammatory neurodegeneration in hippocampus with NMDA/GABA(A)
dysregulation and impaired spatial learning. Am J Physiol Regul
Integr Comp Physiol. 290:R1345–R1356. 2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Pauletto P and Rattazzi M: Inflammation
and hypertension: the search for a link. Nephrol Dial Transplant.
21:850–853. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wei YL, Li XH and Zhou JZ: Prenatal
exposure to lipopolysaccharide results in increases in blood
pressure and body weight in rats. Acta Pharmacol Sin. 28:651–656.
2007. View Article : Google Scholar : PubMed/NCBI
|
15
|
Liao W, Wei Y, Yu C, Zhou J, Li S, et al:
Prenatal exposure to zymosan results in hypertension in adult
offspring rats. Clin Exp Pharmacol Physiol. 35:1413–1418.
2008.PubMed/NCBI
|
16
|
Hao XQ, Zhang HG, Yuan ZB, Yang DL, Hao
LY, et al: Prenatal exposure to lipopolysaccharide alters the
intrarenal renin-angiotensin system and renal damage in offspring
rats. Hypertens Res. 33:76–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Hao XQ, Zhang HG, Li SH, Jia Y, Liu Y, et
al: Prenatal exposure to inflammation induced by zymosan results in
activation of intrarenal renin-angiotensin system in adult
offspring rats. Inflammation. 33:408–414. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, et al: Gene ontology: tool for the unification of
biology. The Gene Ontology Consortium. Nat Genet. 25:25–29. 2000.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhou X and Su Z: EasyGO: Gene
Ontology-based annotation and functional enrichment analysis tool
for agronomical species. BMC Genomics. 8:2462007. View Article : Google Scholar : PubMed/NCBI
|
20
|
Alam-Faruque Y, Huntley RP, Khodiyar VK,
Camon EB, Dimmer EC, et al: The impact of focused Gene Ontology
curation of specific mammalian systems. PLoS One. 6:e275412011.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Dahlquist KD, Salomonis N, Vranizan K,
Lawlor SC and Conklin BR: GenMAPP, a new tool for viewing and
analyzing microarray data on biological pathways. Nat Genet.
31:19–20. 2002. View Article : Google Scholar : PubMed/NCBI
|
22
|
Salomonis N, Hanspers K, Zambon AC,
Vranizan K, Lawlor SC, et al: GenMAPP 2: new features and resources
for pathway analysis. BMC Bioinformatics. 8:2172007.PubMed/NCBI
|
23
|
Doniger SW, Salomonis N, Dahlquist KD,
Vranizan K, Lawlor SC and Conklin BR: MAPPFinder: using Gene
Ontology and GenMAPP to create a global gene-expression profile
from microarray data. Genome Biol. 4:R72003. View Article : Google Scholar : PubMed/NCBI
|